University of Washington
University of Washington tumor board
Questions discussed in this category
Do you only offer it for patients with a documented IgG < 400? Do you check the IgG at all, or are you doing primary prophylaxis?
For many clinical trials, a screening bone marrow biopsy is necessary to get a new baseline. Do you do the same in real-world practice?
For example - minimum number of months of therapy, driving distance to clinic, at least a CR with or without MRD negativity?
Please assume that IVIG is fine (as it is for many Jehovah's Witness patients, since IgG is often not considered a blood product per se).
Would you do a 24-hour urine and echocardiogram in all of these patients? Cardiac biomarkers, PT/PTT, or any other such blood tests?
This question seems quite specific but happens quite often. Multi-drug chemotherapy runs the risk of profound cytopenias and infections, while bispeci...
Modified HyperCVAD? V(R)D-PACE? DCEP? Are there any data to favor one over the other?
Which PI and at what dosing intervals? Dexamethasone or not?
Emory has now published data with VRd consolidation as well as KPd consolidation, while ...
In addition to reversing hypercalcemia, initiating myeloma therapy, etc.
For example, would you use a tool like the Hydrashift assay? Would this change your management?
If tolerated through Cycle #1, how aggressively do you try to titrate the selinexor dose up toward 100mg weekly or 80mg twice-weekly?
And does your a...
In this case, the patient had received daratumumab/lenalidomide/dexamethasone as part of a cooperative group trial. Would you say that the patient had...
Would you consider Dara-CyBorD or a MM triplet/quadruplet such as VRd or Dara-VRd?
19417192861725718931182281787817120165801529814925143581392513482
Papers discussed in this category
Blood, 2016 Mar 21
Amyloid, 2017 Apr 23
Leukemia, 2015 Oct 07
British journal of haematology, 2017-10
Blood Adv,
Blood Cancer J, 2018 May 24
Amyloid, 2019 Jan 20
J. Clin. Oncol., 2019 Oct 25
Journal of the American Society of Nephrology : JASN, 2007-03
Lancet Haematol, 2019 Mar 11
Blood, 2022 Oct 20
The Lancet. Oncology, 2019-01
Haematologica, 2013-01
The Lancet. Haematology, 2015 May 06
European respiratory review : an official journal of the European Respiratory Society, 2017 Sep 06
Mayo Clinic proceedings, 2017-06
Blood Cancer J, 2022 Sep 14
Leukemia & lymphoma, 2021 Feb 03
Dominion law reports, 1990 Mar 30
American journal of hematology, 2019-04
Blood advances, 2023 Mar 28
American journal of hematology, 2023 Jul 08